Urokinase-type plasminogen activator (uPA) is one of the components of blood’s fibrinolytic cascade. uPA acts as a broad spectrum proteolytic enzyme involved in different physio-pathological processes including cellular fibrinolysis, adhesion, migration, invasion and remodeling. Here, we present evidence that uPA participates in myogenesis, a process which requires drastic cell membrane reorganization, leading to the plurinucleated myotube from the progenitor myoblast. We have dissected the expression of uPA throughout the different myogenic compartments and found an increase in uPA enzymatic activity associated with myotube formation in C2C12 myoblast cells, with uPA mRNA increasing prior the onset of fusion and differentiation. When both fusion and differentiation were blocked by specific inhibitors (DMSO, cyto-chalasin B) the levels of uPA were strongly downregulated. This process was reversible and specific: the removal of the inhibitors immediately restored the levels of uPA mRNA while the specific inhibition of uPA enzymatic activity by an anti-uPA antibody resulted in a 50% reduction of the extent of fusion and in the abrogation of muscle-specific gene products, such as a-actin and MyoD. Moreover, the conversion of fibroblasts to muscle-like cells upon acquisition of MyoD resulted in a dramatic increase of uPA mRNA, which was partially due to transcriptional activation of the uPA gene. These results indicate that the increase in uPA expression prior to fusion and differentiation occurs via a MyoD-mediated mechanism whereas the normal MyoD expression requires the plasminogen activation-dependent activity of this protease. Therefore, these studies extend the sphere of influence of myogenic factors to fibrinolysis, an intrinsic component of the hematological system. Taken together, one mechanism used by the myoblast cell to become a differentiated myotube, involving the inductive extracellular proteolysis of urokinase, is proposed.
References
1
Collen D,
Lijnen HR.
Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991; 78: 3114-3124
2
Lijnen HR,
Collen D.
Regulation and control of the fibrinolytic system. In: Serine proteases and their serpin inhibitors in the nervous system.
Festoff BW.
ed.
Plenum Press; New York: 1990. pp 0009-0020
4
Anderson JM,
Swenarchuk LE,
Champaneria S.
Localized extracellular proteolysis may convey inductive signals between nerve and muscle cells during synaptogenesis. In: Serine proteases and their inhibitors in the nervous system.
Festoff BW.
ed.
Plenum Press; New York: 1990. pp 0255-0273
5
Tienari J,
Alanko T,
Lehtonen E,
Saksela O.
The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retionic acid and fibroblast growth factor in human teratocarcinoma cells. Cell Regul 1991; 2: 0285-0297
9
Carmeliet P,
Schoonjans L,
Kieckens L,
Ream B,
Degen J,
Bronson R,
De Vos R,
Van den Oord JJ,
Collen D,
Mulligan RC.
Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368: 0419-0424
10
Carmeliet P,
Bouché A,
De Clercq C,
Pollefeyt S,
Wijns S,
Mulligan RC,
Collen D.
Biological effects of disruption of the tissue-type plasminogen activator, urokinase type plasminogen activator and plasminogen activator inhibitor-1 genes in mice. Ann NY Acad Sci 1995; 7480: 0367
15
Trouche D,
Grigoriev M,
Lenormand J-L,
Robin P,
Leibovitch SA,
Sassone-Corsi P,
Harel-Bellan A.
Repression of c-fos promoter by MyoD on muscle cell differentiation. Nature 1993; 363: 0079-0082
16
Fulton AB,
Prives J,
Farmer SR,
Penman S.
Developmental reorganization of the skeletal framework and its surface lamina in fusing muscle cells. J Cell Biol 1981; 91: 0103-0112
17
Weintraub H,
Davis RL,
Tapscott S,
Thayer M,
Krause M,
Benezra R,
Blackwell TK,
Turner D,
Rupp R,
Hollenberg S,
Zhuang Y,
Lassar AB.
The MyoD gene family: Nodal point during specification of the muscle cell lineage. Science 1991; 251: 0761-0766
18
Boukamp P,
Fusenig NE.
Trans-differentiation from epidermal to mesenchymal/myogenic phenotype is associated with a drastic change in cell-cell and cell-matrix adhesion molecules. J Cell Biol 1993; 120: 0981-0993
19
Weintraub H,
Tapscott SJ,
Davis RL,
Thayer MJ,
Adam MA,
Lassar AB,
Miller AD.
Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci USA 1989; 86: 5434-5438
21
Bengal E,
Ransone L,
Scharfmann R,
Dwarki VJ,
Tapscott SJ,
Weintraub H,
Verma IM.
Functional antagonism between c-jun and MyoD proteins: A direct physical association. Cell 1992; 68: 0507-0519
22
Li L,
Chambard JC,
Karin M,
Olson EN.
Fos and Jun repress transcriptonal activation by myogenin and MyoD: The amino terminus of Jun can mediate repression. Genes Dev 1992; 6: 0676-0689
23
Shimizu M,
Webster C,
Morgan DO,
Blau HM,
Roth RA.
Insulin and insulinlike growth factor receptors and responses in cultured human muscle cells. Am J Physiol 1986; 251: E611-E615
24
Hantai D,
Soria C,
Soria J,
Blondet B,
Barlovatz-Meimom G,
Rao JS,
Festoff BW.
Plasminogen activators in development, injury and pathology of the neuromuscular system. In: Serine proteases and their inhibitors in the nervous system.
Festoff BW.
ed.
Plenun Press; New York: 1991. pp 0219-0229
26
Quax PHA,
Frisdal E,
Pedersen N,
Bonavaud S,
Thiberst PH,
Martelly I,
Verheijen JH,
Blasi F,
Barlovatz-Meimon G.
Modulation of activities and RNA level of the components of the plasminogen activation system during fusion of human myogenic satellite cells in vitro. Dev Biol 1992; 151: 0166-0175
28
Hu MC-T,
Sharp SB,
Davidson D.
The complete sequence of the mouse skeletal alpha-actin genes reveals several conserved and inverted repeat sequences outside of the protein coding region. Mol Cell Biol 1986; 6: 0015-0025
29
Sabath DE,
Broome HE,
Prystowsky MB.
Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced trascript in a cloned T-helper lymphocyte. Gene 1990; 91: 0185-0191
31
Longstaff C,
Clough AM,
Gaffney PJ.
Kinetics of plasmin activation of single chain urinary-type plasminogen activator (scu-PA) and demonstration of a high affinity interaction between scu-PA and plasminogen. J Biol Chem 1992; 267: 0173-0179
36
Ragot T,
Vincent N,
Chafey P,
Vigne E,
Gilgenkrantz H,
Couton D,
Cartaud J,
Briand P,
Kaplan J-C,
Perricaudet M,
Kahn A.
Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 1993; 361: 0647-0650
37
Nadal-Ginard B,
Nguyen HT,
Madhavi V.
Induction of muscle specific genes in the absence of commitment is reversible. Exp Biol Med 1984; 9: 0250-0259
38
Shani M,
Zevin-Sonkin D,
Saxel D,
Carmon Y,
Catcoff D,
Nudel U,
Yaffe D.
The correlation between the synthesis of skeletal muscle actin, myosin heavy chain, and myosin light chain and the accumulation of corresponding mRNA sequences during myogenesis. Dev Biol 1981; 111: 0324-0334
40
Endo T,
Nadal-Ginard B.
Three types of muscle-specific gene expression in fusion-blocked rat skeletal muscle cells: Translational control in EGTA-treated cells. Cell 1987; 49: 0515-0526
41
Miranda AF,
Nette EG,
Khan S,
Brockbank K,
Schonberg M.
Alteration of myoblast phenotype by dimethylsulfoxide. Proc Natl Acad Sci USA 1978; 83: 8511-8515
45
Reznikoff CA,
Brankow DW,
Heidelberger C.
Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res 1977; 33: 3231-3238
48
Barlovatz-Meimon G,
Frisdal E,
Bassaglia Y,
Hantai D,
Angles-Cano E,
Gautron J.
Relationship between plasminogen activators and regeneration capacities of rat skeletal muscles. In: Serine proteases and their serpin inhibitors in the nervous system.
Festoff BW.
ed.
Plenum Press; New York: 1990. pp 0229-0241
52
Guerin CW,
Holland PC.
Synthesis and secretion of matrix-degrading met-alloproteases by human skeletal muscle satellite cells. Dev Dynam 1995; 202: 0091-0099
53
Schafer BW,
Blakely BT,
Darlington GJ,
Blau HM.
Effect of cell history on response to helix-loop-helix family of myogenic regulators. Nature 1990; 344: 0454-0458
56
Brunner G,
Schirrmacher V.
Fibrin autography of plasminogen activator by electrophoretic transfer into fibrin agar gels. Anal Biochem 1988; 168: 0411-0416